Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 498

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 498
---
, prior to the Closing, Kadimastem is traded on the TASE which is not considered as reliable as Nasdaq, where NLS securities are traded. The Merger Agreement provides that, upon the terms and subject to the conditions thereof, following the Closing, NLS shall work diligently to dispose of the Legacy Assets. Therefore, these assets are not intended for use in the combined company’s future operations. It is expected that the proceeds from any sale or disposition of all or any part of the Legacy Assets will be distributed to the shareholders and warrant holders of NLS as of immediately prior to the Effective Time pursuant to the terms and conditions of the CVR Agreement. If a sale is not achieved, the Company does not intend to further develop these assets internally. Due to the uncertainty surrounding the realization of any sale, the likelihood of contingent proceeds is considered remote and of minimal value. Accordingly, these legacy assets and any related contingent distribution have not been recognized in the preliminary valuation.

276

BENEFICIAL OWNERSHIP OF SECURITIES Security Ownership of Certain Beneficial Owners and Management of NLS before the Merger The following tables sets forth information regarding the beneficial ownership of NLS Common Shares as of August28, 2025, by: •each person known by NLS to be the beneficial owner of 5% or more of NLS’s outstanding Common Shares before the consummation of the Merger; •each of its executive officers and directors; •all of its executive officers and directors as a group. Unless otherwise indicated, NLS believes that all persons named in the table will have, immediately before the consummation of the Merger, sole voting and investment power with respect to all NLS’s securities beneficially owned by them. Subject to the paragraph above, percentage ownership of issued shares is based on 4,252,025 NLS Common Shares issued and outstanding as of August28, 2025.

| Name and Address of Beneficial Owner  |     | NLS Common Shares |     |      |     | Voting 
  Power 
    (%) |
| Number(1)                             |     |                 % |     |      |     |        |
| Executive Officers and Directors      |     |                   |     |      |     |        |
| Ronald Hafner(2)                      |     |           557,439 |     | 12.8 |     |   12.8 |
| Alexander C. Zwyer(3)                 |     |             1,